Unlike those in TET2, mutations in TET1 and TET3 are rarely observed in hematological malignancies; however, these two genes are involved in the development of hematological cancers through expression regulation [347, 348]. The gene discussed is TET2; the disease is hematopoietic and lymphoid cell neoplasm.